Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion

M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide

Genin, M., Clement, F., Fattaccioli, A., Raes, M., & Michiels, C. (2015) · BMC Cancer · doi:10.1186/s12885-015-1546-9 · Cited by 1,090 · see citing works

Regulatory T cells in tumor immunity

Nishikawa, H., & Sakaguchi, S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25429 · Cited by 944 · see citing works

Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

Saito, T., Nishikawa, H., Wada, H., Nagano, Y., Sugiyama, D., Atarashi, K., Maeda, Y., Hamaguchi, M., Ohkura, N., Sato, E., et al. (2016) · Nature Medicine · doi:10.1038/nm.4086 · Cited by 871 · see citing works

The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction

Scharping, N. E., Menk, A. V., Moreci, R. S., Whetstone, R. D., Dadey, R. E., Watkins, S. C., Ferris, R. L., & Delgoffe, G. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.009 · Cited by 848 · see citing works

Tumor-associated macrophages: from basic research to clinical application

Yang, L., & Zhang, Y. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0430-2 · Cited by 847 · see citing works

T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis

Facciabene, A., Motz, G. T., & Coukos, G. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3687 · Cited by 820 · see citing works

The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction

Scharping, N. E., Menk, A. V., Moreci, R. S., Whetstone, R. D., Dadey, R., Watkins, S. C., Ferris, R. L., & Delgoffe, G. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.08.009 · Cited by 705 · see citing works

Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression

Ostrand-Rosenberg, S., Sinha, P., Beury, D. W., & Clements, V. K. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.011 · Cited by 583 · see citing works

IL-8 Signaling Plays a Critical Role in the Epithelial–Mesenchymal Transition of Human Carcinoma Cells

Fernando, R. I., Castillo, M. D., Litzinger, M. T., Hamilton, D. H., & Palena, C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0156 · Cited by 400 · see citing works

CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3⁺ regulatory T cells in gastric cancer

Mizukami, Y., Kono, K., Kawaguchi, Y., Akaike, H., Kamimura, K., Sugai, H., & Fujii, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.23392 · Cited by 374 · see citing works

Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells

Singh, J. K., Simões, B. M., Howell, S. J., Farnie, G., & Clarke, R. B. (2013) · Breast Cancer Research · doi:10.1186/bcr3436 · Cited by 250 · see citing works

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

Filipazzi, P., Huber, V., & Rivoltini, L. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1161-9 · Cited by 244 · see citing works

Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer

Suzuki, H., Chikazawa, N., Tasaka, T., 和田, 純., Yamasaki, A., Kitaura, Y., Sozaki, M., Tanaka, M., Onishi, H., Morisaki, T., et al. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-009-0781-9 · Cited by 180 · see citing works

FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer

Fu, X., Jeselsohn, R. M., Pereira, R., Hollingsworth, E. F., Creighton, C. J., Li, F., Shea, M. J., Nardone, A., Angelis, C. D., Heiser, L. M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612835113 · Cited by 169 · see citing works

Influence of IL-8 on The Epithelial–Mesenchymal Transition and the Tumor Microenvironment

Palena, C., Hamilton, D. H., & Fernando, R. I. (2012) · Future Oncology · doi:10.2217/fon.12.59 · Cited by 166 · see citing works

IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review)

LONG, X., Ye, Y., Zhang, L., Liu, P., Yu, W., Wei, F., Ren, X., & Yu, J. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3234 · Cited by 153 · see citing works

Interleukin-8 and Interleukin-17 for Cancer

Zarogoulidis, P., Katsikogianni, F., Tsiouda, T., Sakkas, A., Katsikogiannis, N., & Zarogoulidis, P. (2014) · Cancer Investigation · doi:10.3109/07357907.2014.898156 · Cited by 115 · see citing works

Clinical relevance of the tumor microenvironment and immune escape of oral squamous cell carcinoma

Eckert, A. W., Wickenhauser, C., Salins, P. C., Kappler, M., Bukur, J., & Seliger, B. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0828-6 · Cited by 108 · see citing works

Cancer cell-derived IL-1α induces CCL22 and the recruitment of regulatory T cells

Wiedemann, G. M., Knott, M. M. L., Vetter, V. K., Rapp, M., Haubner, S., Fesseler, J., Kühnemuth, B., Layritz, P., Thaler, R., Krüger, S., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1175794 · Cited by 107 · see citing works

CCL22 Recruits CD4-positive CD25-positive Regulatory T Cells into Malignant Pleural Effusion

Qin, X., Shi, H., Deng, J., Liang, Q.-L., Jiang, J., & Ye, Z. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2641 · Cited by 94 · see citing works

CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients

Li, Y., Wang, F., Wang, L., Huang, L. J., Wang, J., Zhang, B., & Zhang, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3547 · Cited by 93 · see citing works

Intrahepatic IL-8 producing Foxp3+CD4+ regulatory T cells and fibrogenesis in chronic hepatitis C

Langhans, B., Krämer, B., Louis, M., Nischalke, H. D., Hüneburg, R., Staratschek-Jox, A., Odenthal, M., Manekeller, S., Schepke, M., Kalff, J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.011 · Cited by 89 · see citing works

CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma

Maruyama, T., Kono, K., Izawa, S., Mizukami, Y., Kawaguchi, Y., Mimura, K., Watanabe, M., & Fujii, H. (2009) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2009.01029.x · Cited by 84 · see citing works

Impaired T cell function in malignant pleural effusion is caused by TGF‐β derived predominantly from macrophages

Li, L., Li, Y., Wang, L., Wang, F., Zhang, Z., Li, J., Yue, D., Chen, X., Yü, P., Huang, L. J., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30289 · Cited by 82 · see citing works

Fucoidan inhibits CCL22 production through NF-κB pathway in M2 macrophages: a potential therapeutic strategy for cancer

Sun, J. T., Sun, J., Song, B., Zhang, L., Shao, Q., Liu, Y., Yuan, D., Zhang, Y., & Qu, X. (2016) · Scientific Reports · doi:10.1038/srep35855 · Cited by 81 · see citing works

CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment

Martinenaite, E., Ahmad, S. M., Hansen, M., Met, Ö., Westergaard, M. C. W., Larsen, S. K., Klausen, T. W., Donia, M., Svane, I. M., & Andersen, M. H. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1238541 · Cited by 80 · see citing works

Management of Malignant Pleural Effusion

Kastelik, J. A. (2013) · Lung · doi:10.1007/s00408-012-9445-1 · Cited by 79 · see citing works

Suppression of Intratumoral CCL22 by Type I Interferon Inhibits Migration of Regulatory T Cells and Blocks Cancer Progression

Anz, D., Rapp, M., Eiber, S., Koelzer, V. H., Thaler, R., Haubner, S., Knott, M. M. L., Nagel, S., Golić, M., Wiedemann, G. M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3499 · Cited by 78 · see citing works

CD4+CD25+ Regulatory T Lymphocytes in Malignant Pleural Effusion

Chen, Y., Shi, H., Qin, X., Mo, W., Liang, X.-D., Huang, Z.-X., Yang, H., & Wu, C. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200504-588oc · Cited by 75 · see citing works

Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model

Chang, D.-K., Peterson, E., Sun, J., Goudie, C., Drapkin, R., Liu, J. F., Matulonis, U. A., Zhu, Q. K., & Marasco, W. A. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1090075 · Cited by 72 · see citing works

CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion

Wang, F., Li, Y., Gao, Q., Huang, L. J., Wang, L., Wang, J., Wang, S., Zhang, B., & Zhang, Y. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1701-9 · Cited by 56 · see citing works

Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer

Barrera, L., Montes-Servín, E., Hernandez‐Martinez, J., Orozco‐Morales, M., Montes-Servín, E., Michel-Tello, D., Morales-Flores, R. A., Flores‐Estrada, D., & Arrieta, O. G. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2196-y · Cited by 54 · see citing works

Interleukin-8 is related to poor chemotherapeutic response and tumourigenicity in hepatocellular carcinoma

Park, S., Han, J., Kim, J. B., Yang, M.-G., Kim, Y. J., Lim, H., An, S. Y., & Kim, J. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.09.021 · Cited by 43 · see citing works

CCL22 is involved in the recruitment of CD4+CD25high T cells into tuberculous pleural effusions

Wu, C., Zhou, Q., Xue‐Jun, Q. I. N., Qin, S., & Shi, H. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01719.x · Cited by 34 · see citing works

Allopurinol suppresses expression of the regulatory T‐cell migration factors TARC/CCL17 and MDC/CCL22 in HaCaT keratinocytes via restriction of nuclear factor‐κB activation

Osabe, M., Tajika, T., & Tohkin, M. (2017) · Journal of Applied Toxicology · doi:10.1002/jat.3522 · Cited by 17 · see citing works

Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma

An, H., Zhu, Y., Xie, H., Liu, Y., Liu, W., Fu, Q., Ye, D., & Xu, J. (2015) · Tumor Biology · doi:10.1007/s13277-015-4158-8 · Cited by 13 · see citing works

Management of malignant pleural effusion

Simpson, G., & Judge, D. J. (2014) · Respirology · doi:10.1111/resp.12447 · Cited by 9 · see citing works

The Optimal Management of Malignant Pleural Effusion: Steady Progress Towards an Evidence-Based Approach

Koegelenberg, C. F. N., & Allwood, B. (2018) · Respiration · doi:10.1159/000492032 · Cited by 5 · see citing works

Immunosenescence: molecular mechanisms and diseases

Liu, Z., Liang, Q., Ren, Y., Guo, C., Ge, X., Wang, L., Cheng, Q., Luo, P., Zhang, Y., & Han, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01451-2 · Cited by 1,023 · see citing works

Targeting tumor-associated macrophages to synergize tumor immunotherapy

Xiang, X., Wang, J., Lu, D., & Xu, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00484-9 · Cited by 982 · see citing works

Immunosenescence: a key player in cancer development

Lian, J., Yue, Y., Yu, W., & Zhang, Y. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00986-z · Cited by 510 · see citing works

Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review

Oura, K., Morishita, A., Tani, J., & Masaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115801 · Cited by 433 · see citing works

Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities

Chen, L., Rong, D., Zhang, B., Zheng, W., Wang, X., Chen, Z., & Tang, W. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1047-6 · Cited by 416 · see citing works

T Cell Dysfunction and Exhaustion in Cancer

Zhang, Z., Liu, S., Zhang, B., Qiao, L., Zhang, Y., & Zhang, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00017 · Cited by 385 · see citing works

Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments

Xu, J., Ding, L., Mei, J., Hu, Y., Kong, X., Dai, S., Bu, T., Xiao, Q., & Ding, K. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02325-5 · Cited by 356 · see citing works

Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression

Saleh, R., & Elkord, E. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.017 · Cited by 292 · see citing works

The Crosstalk Between Tumor-Associated Macrophages (TAMs) and Tumor Cells and the Corresponding Targeted Therapy

Ge, Z., & Ding, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.590941 · Cited by 224 · see citing works

Refining colorectal cancer classification and clinical stratification through a single-cell atlas

Khaliq, A. M., Erdoğan, C., Kurt, Z., Turgut, S. S., Grunvald, M. W., Rand, T., Khare, S., Borgia, J. A., Hayden, D. M., Pappas, S. G., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02677-z · Cited by 223 · see citing works

Decoding the spatiotemporal heterogeneity of tumor-associated macrophages

Chu, X., Tian, Y., & Lv, C. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02064-1 · Cited by 231 · see citing works

Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment

Yang, L., Li, A., Lei, Q., & Zhang, Y. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0804-8 · Cited by 215 · see citing works

Tumor-associated macrophages remodel the suppressive tumor immune microenvironment and targeted therapy for immunotherapy

Yang, Y., Li, S., To, K. K. W., Zhu, S., Wang, F., & Fu, L. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03377-9 · Cited by 195 · see citing works

Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy

Liu, Z., Zhou, Z., Dang, Q., Xu, H. M., Lv, J., Li, H., & Han, X. (2022) · Theranostics · doi:10.7150/thno.76854 · Cited by 198 · see citing works

Transforming Growth Factor-β: A Multifunctional Regulator of Cancer Immunity

Xue, V. W., Chung, J. Y., Córdoba, C. A. G., Cheung, A. H. K., Kang, W., Lam, E. W. ‐., Leung, K. T., To, K., Lan, H. Y., & Tang, P. M. (2020) · Cancers · doi:10.3390/cancers12113099 · Cited by 149 · see citing works

Macrophage polarization in THP-1 cell line and primary monocytes: A systematic review

Yasin, Z. N. M., Idrus, F. N. M., Hoe, C. H., & Yvonne-Τee, G. B. (2022) · Differentiation · doi:10.1016/j.diff.2022.10.001 · Cited by 143 · see citing works

Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy

Han, Z., Li, Y.-B., Yang, L., Cheng, H., Liu, X., & Chen, H. (2021) · Molecules · doi:10.3390/molecules27010137 · Cited by 138 · see citing works

Next frontier in tumor immunotherapy: macrophage-mediated immune evasion

Qiu, Y., Chen, T., Hu, R., Zhu, R., Li, C., Ruan, Y., Xie, X., & Li, Y. (2021) · Biomarker Research · doi:10.1186/s40364-021-00327-3 · Cited by 134 · see citing works

Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities

Wang, G., Zhong, K., Wang, Z., Zhang, Z., Tang, X., Tong, A., & Zhou, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.964898 · Cited by 129 · see citing works

Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy

Zheng, H.-Y., Peng, X.-Q., Yang, S., Li, X., Huang, M.-Y., Wei, S.-B., Zhang, S., He, G., Liu, J., Fan, Q., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01356-7 · Cited by 112 · see citing works

Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions

Zhang, C., Zhang, C., & Wang, H. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216182 · Cited by 125 · see citing works

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma

Peng, Y., Liu, C., Li, M., Li, W., Zhang, M., Jiang, X. W., Chang, Y., Liu, L., Wang, F., & Zhao, Q. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01792-4 · Cited by 106 · see citing works

Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas

Wei, C., Wang, B., Peng, D., Zhang, X., Li, Z., Luo, L., He, Y., Liang, H., Du, X., Li, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.849592 · Cited by 99 · see citing works

The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma

Huang, Y., Ge, W.-H., Zhou, J.-R., Gao, B.-Q., Qian, X.-H., & Wang, W.-L. (2021) · Journal of Cancer · doi:10.7150/jca.51346 · Cited by 93 · see citing works

Role of macrophages in tumor progression and therapy (Review)

Xu, Y., Wang, X., Liu, L., Wang, J., Wu, J., & Sun, C. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5347 · Cited by 89 · see citing works

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression

Kotsari, M., Dimopoulou, V., Koskinas, J. S., & Armakolas, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411471 · Cited by 86 · see citing works

Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses

Foglia, B., Beltrà, M., Sutti, S., & Cannito, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087463 · Cited by 81 · see citing works

Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm

Wang, T., Dai, L., Shen, S. Y., Yang, Y., Yang, M., Yang, X., Qiu, Y., & Wang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.843408 · Cited by 78 · see citing works

Targeting macrophages: a novel treatment strategy in solid tumors

Liu, M., Liu, L., Song, Y.-P., Li, W., & Xu, L. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03813-w · Cited by 65 · see citing works

Tumor‑associated macrophages in lung cancer: Friendly or evil? (Review)

Xu, F., Wei, Y., Tang, Z., Liu, B., & Dong, J. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11518 · Cited by 67 · see citing works

Macrophage-derived CCL23 upregulates expression of T-cell exhaustion markers in ovarian cancer

Kamat, K. D., Krishnan, V., & Dorigo, O. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01887-3 · Cited by 61 · see citing works

MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication Between Kupffer Cells and Regulatory T Cells

Liu, N., Chang, C.-W., Steer, C. J., Wang, X. W., & Song, G. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.10.015 · Cited by 56 · see citing works

Fn-Dps, a novel virulence factor of Fusobacterium nucleatum, disrupts erythrocytes and promotes metastasis in colorectal cancer

Wu, Y., Guo, S., Chen, F., Li, Y., Huang, Y., Liu, W., & Zhang, G. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011096 · Cited by 54 · see citing works

Macrophages as key regulators of liver health and disease

Papachristoforou, E., & Ramachandran, P. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.006 · Cited by 55 · see citing works

Bright future or blind alley? CAR-T cell therapy for solid tumors

Zhang, K., Chen, H., Li, F., Sheng, H., Chen, F., & Li, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1045024 · Cited by 44 · see citing works

Single-cell profiling reveals immune disturbances landscape and HLA-F-mediated immune tolerance at the maternal-fetal interface in preeclampsia

Luo, F., Liu, F., Guo, Y., Xu, W., Li, Y., Yi, J., Fournier, T., Degrelle, S. A., Zitouni, H., Hernandez, I., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1234577 · Cited by 41 · see citing works

Lactic acid: The culprit behind the immunosuppressive microenvironment in hepatocellular carcinoma

Peng, X., He, Z., Yuan, D., Liu, Z., & Rong, P. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189164 · Cited by 44 · see citing works

The Interplay between T Cells and Cancer: The Basis of Immunotherapy

Chen, C., Liu, X., Chang, C., Wang, H. Y., & Wang, R. (2023) · Genes · doi:10.3390/genes14051008 · Cited by 39 · see citing works

Epigenetic regulation and therapeutic targets in the tumor microenvironment

Xie, Z., Zhou, Z., Yang, S., Zhang, S., & Shao, B. (2023) · Molecular Biomedicine · doi:10.1186/s43556-023-00126-2 · Cited by 38 · see citing works

Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review)

Su, P., Li, O., Ke, K., Jiang, Z., Wu, J., Wang, Y., Mou, Y., & Jin, W. (2024) · International Journal of Oncology · doi:10.3892/ijo.2024.5648 · Cited by 37 · see citing works

Bringing Macrophages to the Frontline against Cancer: Current Immunotherapies Targeting Macrophages

Reis-Sobreiro, M., da Mota, A. T., Jardim, C., & Serre, K. (2021) · Cells · doi:10.3390/cells10092364 · Cited by 37 · see citing works

Immunosenescence and cancer: Opportunities and challenges

Fu, Z., Xu, H., Yue, L., Zheng, W., Pan, L., Gao, F., & Liu, X. (2023) · Medicine · doi:10.1097/md.0000000000036045 · Cited by 36 · see citing works

Interaction of tumor‑associated macrophages with stromal and immune components in solid tumors: Research progress (Review)

Казакова, А., Sudarskikh, T., Kovalev, O. I., Kzhyshkowska, J. G., & Larionova, I. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5480 · Cited by 34 · see citing works

Co-evolution of glioma and immune microenvironment

Elguindy, M. M., Young, J. S., Ho, W. S., & Lu, R. O. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009175 · Cited by 35 · see citing works

Immune Microenvironment and the Effect of Vascular Endothelial Growth Factor Inhibition in Hepatocellular Carcinoma

Oura, K., Morishita, A., Tadokoro, T., Fujita, K., Tani, J., & Kobara, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413590 · Cited by 33 · see citing works

Monocyte-Derived Leukemia-Associated Macrophages Facilitate Extramedullary Distribution of T-cell Acute Lymphoblastic Leukemia Cells

Yang, F., Feng, W., Wang, H., Wang, L., Liu, X., Wang, R., Chen, C., Yang, X. Q., Zhang, D., Ren, Q., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0034 · Cited by 33 · see citing works

SAMD9 Is Relating With M2 Macrophage and Remarkable Malignancy Characters in Low-Grade Glioma

Ma, W., Zhang, K., Bao, Z., Jiang, T., & Zhang, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.659659 · Cited by 33 · see citing works

ROS in hepatocellular carcinoma: What we know

Xing, L., Tang, Y., Li, L., & Tao, X. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109699 · Cited by 32 · see citing works

Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction

Rana, P. S., Soler, D. C., Kort, J., & Driscoll, J. J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1059715 · Cited by 34 · see citing works

Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion

Shao, M., Pei, X., Chen, Q., Wang, F., Wang, Z., & Zhai, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161375 · Cited by 32 · see citing works

Glucose metabolism and tumour microenvironment in pancreatic cancer: A key link in cancer progression

Dong, S., Li, W., Li, X., Wang, Z., Zhou, C., Shi, H., He, R., Chen, C., & Zhou, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1038650 · Cited by 32 · see citing works

Macrophage-mediated cancer drug delivery

Wang, H., Liu, Y., Yang, G., & Zhao, C. (2020) · Materials Today Sustainability · doi:10.1016/j.mtsust.2020.100055 · Cited by 31 · see citing works

Hofbauer Cells Spread Listeria monocytogenes among Placental Cells and Undergo Pro-Inflammatory Reprogramming while Retaining Production of Tolerogenic Factors

Azari, S., Johnson, L. J., Webb, A., Kozlowski, S. M., Zhang, X., Rood, K. M., Amer, A. O., & Seveau, S. M. (2021) · mBio · doi:10.1128/mbio.01849-21 · Cited by 31 · see citing works

circ_0004140 promotes LUAD tumor progression and immune resistance through circ_0004140/miR-1184/CCL22 axis

Liu, Y., Zhang, H., Zhang, W., Xiang, L., Yin, Z., Xu, H., Lu, P., Ma, Y., Xiong, L., Zhang, X., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00983-w · Cited by 31 · see citing works

Tumor-associated macrophages in cancer: from mechanisms to application

Tang, W., Wang, X., Han, B., Jiang, S.-H., & Cao, H. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00396-y · Cited by 30 · see citing works

Deciphering Treg cell roles in esophageal squamous cell carcinoma: a comprehensive prognostic and immunotherapeutic analysis

Zhang, P., Dong, S., Sun, W., Zhong, W., Xiong, J., Gong, X., Li, J., Lin, H., & Yu, Z. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1277530 · Cited by 29 · see citing works

TMEM205 Is an Independent Prognostic Factor and Is Associated With Immune Cell Infiltrates in Hepatocellular Carcinoma

Rao, J., Wu, X., Zhou, X., Deng, R., & Ma, Y. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.575776 · Cited by 29 · see citing works

Combined mild magnetic hyperthermia and calcium ion regulation for enhanced immunotherapy of orthotopic liver cancer

Chen, L., Ren, W., Bao, Q., Hu, P., Fang, W., Wu, T., & Shi, J. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102284 · Cited by 28 · see citing works

Identification of an Immune-Related Gene Signature to Improve Prognosis Prediction in Colorectal Cancer Patients

Dai, S., Xu, S., Yao, Y., & Ding, K. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.607009 · Cited by 27 · see citing works

Engineering Macrophages via Nanotechnology and Genetic Manipulation for Cancer Therapy

Ding, X., Sun, X., Cai, H., Wu, L., Liu, Y., Zhao, Y., Zhou, D., Yu, G., & Zhou, X. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.786913 · Cited by 28 · see citing works

Th17 cells and their related cytokines: vital players in progression of malignant pleural effusion

Niu, Y.-R., & Zhou, Q. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04227-z · Cited by 27 · see citing works

Glioma–Immune Cell Crosstalk in Tumor Progression

Elguindy, M. M., Young, J. S., Mondal, I., Lu, R. O., & Ho, W. S. (2024) · Cancers · doi:10.3390/cancers16020308 · Cited by 27 · see citing works

Immune modulation in malignant pleural effusion: from microenvironment to therapeutic implications

Ge, S., Zhao, Y., Liang, J., He, Z., Li, K., Zhang, G., Hua, B., Zheng, H., Guo, Q., Qi, R., et al. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03211-w · Cited by 27 · see citing works

Helper T cells in malignant pleural effusion

Yi, F., Zhai, K., & Shi, H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.12.016 · Cited by 26 · see citing works

Identification of TGF-β signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer

Zeng, C., He, R. X., Dai, Y., Lu, X., Deng, L., Zhu, Q., Liu, Y., Liu, Q., Lu, W., Wang, Y., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1069204 · Cited by 26 · see citing works

L1CAM Overexpression Promotes Tumor Progression Through Recruitment of Regulatory T Cells in Esophageal Carcinoma

Zhao, X., Liu, S., Chen, X., Zhao, J., Li, F., Zhao, Q., Xie, T., Huang, L., Zhang, Z., Qi, Y., et al. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0182 · Cited by 25 · see citing works

Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers

Wu, D., Liu, X., Mu, J., Yang, J., Wu, F., & Zhou, H. (2022) · Biomolecules · doi:10.3390/biom12030392 · Cited by 25 · see citing works

Senescent Stromal Cells in the Tumor Microenvironment: Victims or Accomplices?

Ye, M., Huang, X., Wu, Q., & Liu, F. (2023) · Cancers · doi:10.3390/cancers15071927 · Cited by 26 · see citing works

Tumor-associated macrophages in non-small-cell lung cancer: From treatment resistance mechanisms to therapeutic targets

Huang, Z., Xiao, Z., Yu, L., Liu, J., Yang, Y., & Ouyang, W. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104284 · Cited by 25 · see citing works

CKMT1B is a potential prognostic biomarker and associated with immune infiltration in Lower-grade glioma

Shi, H., Song, Y., Song, Z. Q., & Huang, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245524 · Cited by 24 · see citing works

Unveiling the contribution of tumor-associated macrophages in driving epithelial-mesenchymal transition: a review of mechanisms and therapeutic Strategies

Zhang, Y., Ding, X., Zhang, X., Li, Y., Xu, R. C., Li, H., Zuo, D., & Chen, G. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1404687 · Cited by 23 · see citing works

Bioinformatic Analysis of the CXCR2 Ligands in Cancer Processes

Korbecki, J., Bosiacki, M., Chlubek, D., & Baranowska‐Bosiacka, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713287 · Cited by 23 · see citing works

Hepatocellular Carcinoma Tumor Microenvironment and Its Implications in Terms of Anti-tumor Immunity: Future Perspectives for New Therapeutics

Satılmış, B., Şahin, T. T., Çiçek, E., Akbulut, S., & Yılmaz, S. (2021) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-021-00725-8 · Cited by 24 · see citing works

Cancer cell plasticity defines response to immunotherapy in cutaneous squamous cell carcinoma

Lorenzo-Sanz, L., Lopez-Cerda, M., da Silva-Diz, V., Artés, M. H., Llop, S., Penín, R., Bermejo, J., González-Suárez, E., Esteller, M., Viñals, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49718-8 · Cited by 22 · see citing works

Tumor‐Associated Macrophages: Key Players in the Non‐Small Cell Lung Cancer Tumor Microenvironment

Lv, T., Fan, R., Wu, J., Gong, H., Gao, X., Liu, X., Gong, Y., Luo, B., Zhang, Y., Peng, X., et al. (2025) · Cancer Medicine · doi:10.1002/cam4.70670 · Cited by 22 · see citing works

PITX1 suppresses osteosarcoma metastasis through exosomal LINC00662-mediated M2 macrophage polarization

Zhang, Y., Chen, Y., Chen, C., Guo, H., Zhou, C., Wang, H., & Liu, Z. (2022) · Clinical & Experimental Metastasis · doi:10.1007/s10585-022-10192-5 · Cited by 22 · see citing works

M1 macrophages polarized by crude polysaccharides isolated from Auricularia polytricha exhibit anti-tumor effect on human breast cancer cells

Nilkhet, S., Mongkolpobsin, K., Sillapachaiyaporn, C., Wongsirojkul, N., Tencomnao, T., & Chuchawankul, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-58208-2 · Cited by 21 · see citing works

Macrophages Orchestrate the Liver Tumor Microenvironment

Quaranta, V., Ballarò, C., & Giannelli, G. (2024) · Cancers · doi:10.3390/cancers16091772 · Cited by 21 · see citing works

The role of tumor-associated macrophages in lung cancer

Zhu, R., Huang, J., & Qian, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1556209 · Cited by 17 · see citing works

Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression

Karger, A., Nandigama, R., Stenzinger, A., Grimminger, F., Pullamsetti, S. S., Seeger, W., & Savai, R. (2021) · Cancers · doi:10.3390/cancers13164127 · Cited by 20 · see citing works

Pexidartinib synergize PD-1 antibody through inhibiting treg infiltration by reducing TAM-derived CCL22 in lung adenocarcinoma

Zhang, W., Jiang, X., Zou, Y., Yuan, L., & Wang, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1092767 · Cited by 20 · see citing works

T cell landscape in the microenvironment of human solid tumors

Maggi, E., Munari, E., Landolina, N., Mariotti, F. R., Azzarone, B. G., & Moretta, L. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106942 · Cited by 21 · see citing works

Characteristics of Malignant Pleural Effusion Resident CD8+ T Cells from a Heterogeneous Collection of Tumors

Dhupar, R., Okusanya, O. T., Eisenberg, S. H., Monaco, S. E., Ruffin, A. T., Liu, D., Luketich, J. D., Kammula, U. S., Bruno, T. C., Lotze, M. T., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176178 · Cited by 20 · see citing works

Subverted macrophages in the triple-negative breast cancer ecosystem

Shang, L., Zhong, Y., Yao, Y., Liu, C., Wang, L., Zhang, W., Liu, J., Wang, X., & Sun, C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115414 · Cited by 20 · see citing works

The molecular landscape of T cell exhaustion in the tumor microenvironment and reinvigoration strategies

Heidari‐Foroozan, M., Rezalotfi, A., & Rezaei, N. (2024) · International Reviews of Immunology · doi:10.1080/08830185.2024.2401352 · Cited by 18 · see citing works

Unusual Association of NF-κB Components in Tumor-Associated Macrophages (TAMs) Promotes HSPG2-Mediated Immune-Escaping Mechanism in Breast Cancer

Paolis, V. D., Maiullari, F., Chirivì, M., Milan, M., Cordiglieri, C., Pagano, F., Manna, A. R. L., FALCO, E. D., Bearzi, C., Rizzi, R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147902 · Cited by 18 · see citing works

The DARC Side of Inflamm-Aging: Duffy Antigen Receptor for Chemokines (DARC/ACKR1) as a Potential Biomarker of Aging, Immunosenescence, and Breast Oncogenesis among High-Risk Subpopulations

Jinna, N., Rida, P. C. G., Su, T., Gong, Z., Yao, S., LaBarge, M. A., Natarajan, R. D., Jovanović‐Talisman, T., Ambrosone, C. B., & Seewaldt, V. L. (2022) · Cells · doi:10.3390/cells11233818 · Cited by 18 · see citing works

CCL17 acts as an antitumor chemokine in micromilieu‐driven immune skewing

Li, Y., Cao, H., Jiang, Z., Yan, K., Shi, J., Wang, S., Wang, F., Wang, W., Li, X., Sun, N., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110078 · Cited by 17 · see citing works

Targeting Macrophages for Tumor Therapy

Wang, Y., Barrett, A., & Hu, Q. (2023) · The AAPS Journal · doi:10.1208/s12248-023-00845-y · Cited by 17 · see citing works

Epigenetic Mechanisms Driving Tumor Supportive Microenvironment Differentiation and Function: A Role in Cancer Therapy?

Sylvestre, M., Tarte, K., & Roulois, D. (2019) · Epigenomics · doi:10.2217/epi-2019-0165 · Cited by 17 · see citing works

Cistanche deserticola polysaccharides extracted from Cistanche deserticola Y.C. Ma promote the differentiation of mouse female germline stem cells in vitro

Qiu, Y., Zhang, Y., Ren, H., Zhang, Y., Liu, X., Pu, J., Yu, J., Yu, X., & Pei, X. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115495 · Cited by 16 · see citing works

Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA

Kim, J., Pena, J., McQueen, H. P., Kong, L., Michael, D., Lomashvili, E. M., & Cook, P. R. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00678-z · Cited by 16 · see citing works

Cellular senescence in the tumor with a bone niche microenvironment: friend or foe?

Alavimanesh, S., Jazi, N. N., Choubani, M., Saeidi, F., Afkhami, H., Yarahmadi, A., Ronaghi, H., Khani, P., & Modarressi, M. H. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01564-8 · Cited by 17 · see citing works

Efferocytosis fuels malignant pleural effusion through TIMP1

Zhao, L., Giannou, A. D., Xu, Y., Shiri, A. M., Liebold, I., Steglich, B., Bedke, T., Zhang, T., Lücke, J., Scognamiglio, P., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd6734 · Cited by 15 · see citing works

Targeting tumor-associated macrophages: Novel insights into immunotherapy of skin cancer

Liu, J., Lu, J., Wu, L., Zhang, T., Wu, J., Li, L., Tai, Z., Chen, Z., & Zhu, Q. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.01.013 · Cited by 15 · see citing works

Glioblastoma: Molecular features, emerging molecular targets and novel therapeutic strategies

Politis, A. A., Stavrinou, L. C., Kalyvas, A., Boviatsis, E. I., & Piperi, C. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104764 · Cited by 15 · see citing works

New insights into T-cell exhaustion in liver cancer: from mechanism to therapy

Hao, L., Li, S., & Hu, X. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05083-5 · Cited by 14 · see citing works

Macrophages as Targets in Hepatocellular Carcinoma Therapy

Liu, Y., Mao, Z., Ding, Y., & Wang, W. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0660 · Cited by 14 · see citing works

Single‐cell transcriptomics reveal metastatic CLDN4+ cancer cells underlying the recurrence of malignant pleural effusion in patients with advanced non‐small‐cell lung cancer

Zhang, X., Wang, X., Wen, Y., Chen, S., Zhou, C., & Wu, F. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1649 · Cited by 14 · see citing works

Macrophages: Key Players in the Battle against Triple-Negative Breast Cancer

Padzińska-Pruszyńska, I. B., Kucharzewska, P., Matejuk, A., Górczak, M., Kubiak, M., Taciak, B., & Król, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910781 · Cited by 14 · see citing works

CCL22 Recruits CD4-positive CD25-positive Regulatory T Cells into Malignant Pleural Effusion

Qin, X., Shi, H., Deng, J., Liang, Q.-L., Jiang, J., & Ye, Z. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2641 · Cited by 94 · see citing works

Impaired T cell function in malignant pleural effusion is caused by TGF‐β derived predominantly from macrophages

Li, L., Li, Y., Wang, L., Wang, F., Zhang, Z., Li, J., Yue, D., Chen, X., Yü, P., Huang, L. J., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30289 · Cited by 82 · see citing works

Enhanced Suppressive Activity of Regulatory T Cells in the Microenvironment of Malignant Pleural Effusions

Budna, J., Kaczmarek, M., Kolecka-Bednarczyk, A., Spychalski, Ł., Zawierucha, P., Goździk-Spychalska, J., Nowicki, M. O., Batura‐Gabryel, H., & Sikora, J. (2018) · Journal of Immunology Research · doi:10.1155/2018/9876014 · Cited by 20 · see citing works

Pleural Effusion of Patients with Malignant Mesothelioma Induces Macrophage-Mediated T Cell Suppression

Lievense, L. A., Cornelissen, R., Bezemer, K., Kaijen-Lambers, M. E. H., Hegmans, J. P., & Aerts, J. G. J. V. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.06.021 · Cited by 86 · see citing works

CXCL2/CXCR2 pathway regulates CD169high large macrophages to promote progression of malignant pleural effusion from lung adenocarcinoma

Chen, S., Li, C., Sun, Y., Huang, Y., Gong, G., Bao, Y., & Xu, L. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1943314